tiprankstipranks
Isracann Biosciences (TSE:IPOT)
CNQX:IPOT

Isracann Biosciences (IPOT) Financial Statements

36 Followers

Isracann Biosciences Financial Overview

Isracann Biosciences's market cap is currently ―. The company's EPS TTM is C$; its P/E ratio is ―; Isracann Biosciences is scheduled to report earnings on October 26, 2023, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Aug 22May 22Feb 22Nov 21Aug 21
Income Statement-
Total Revenue--C$ 0.00C$ 0.00C$ 0.00
Gross Profit-----
EBITC$ -316.00K-C$ -620.14KC$ -873.94KC$ -454.69K
EBITDAC$ -305.56K-C$ -609.71KC$ -863.51KC$ -444.26K
Net Income Common StockholdersC$ -316.00K-C$ -620.14KC$ -873.94KC$ -469.10K
Balance Sheet-
Cash Cash Equivalents And Short Term InvestmentsC$ 198.05KC$ 213.94KC$ 310.61KC$ 826.68KC$ 1.40M
Total AssetsC$ 4.04MC$ 4.09MC$ 2.78MC$ 3.41MC$ 3.93M
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -198.05KC$ -213.94KC$ -310.61KC$ -826.68KC$ -1.40M
Total LiabilitiesC$ 3.91MC$ 3.80MC$ 747.88KC$ 769.87KC$ 459.77K
Stockholders EquityC$ 128.16KC$ 293.66KC$ 2.04MC$ 2.64MC$ 3.47M
Cash Flow-
Free Cash FlowC$ -163.40KC$ -215.23KC$ -521.63KC$ -574.97KC$ -442.73K
Operating Cash FlowC$ -163.40KC$ -215.23KC$ -521.63KC$ -574.97KC$ -442.73K
Investing Cash Flow-C$ 39.46KC$ 0.00C$ 0.00C$ -116.61K
Financing Cash FlowC$ 151.55KC$ 129.91KC$ 0.00C$ 0.00C$ 0.00
Currency in CAD

Isracann Biosciences Earnings and Revenue History

Isracann Biosciences Debt to Assets

Isracann Biosciences Cash Flow

Isracann Biosciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis